FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620007152> ?p ?o ?g. }

• W2620007152 endingPage "798" @default.
• W2620007152 startingPage "791" @default.
• W2620007152 abstract "The opioid epidemic continues to impact the United States, and new strategies are needed to combat this epidemic. The objective of this study was to analyze 2015 drug arrest data from Maine's Diversion Alert (DA) program (diversionalert.org), compare arrest data between the first quarters of 2015 and 2016, and provide an analysis of the sex differences in the arrests as well as information about DA use.This was a population-based descriptive study using data from the Maine DA program. The study population consisted of persons arrested for prescription, nonprescription, or illicit drugs.DA database.The DA program addresses Maine's prescription drug abuse epidemic with innovative resources that provide access to drug arrest data for health care providers to identify and respond to patients at risk for overdose, those engaged in illegal prescription drug distribution, and those who need treatment. Drug arrest data from 2015 (2723 arrests) and the first quarter of 2016 (788 arrests) were compared and analyzed. The drugs implicated in the arrests were organized by Drug Enforcement Agency (DEA) schedule category and whether they were pharmaceuticals (synthesized and distributed by a pharmaceutical company) or nonpharmaceuticals (grown or synthesized in clandestine laboratories). Most arrests were for possession (64.5%) followed by trafficking (23.8%). Heroin was listed in more than three-quarters (76.4%) of the Schedule I arrests, followed by marijuana (11.7%) and bath salts (6.3%). Cocaine and crack cocaine were implicated in almost half (46.7%) of the Schedule II arrests, followed by oxycodone (21.0%) and methamphetamine/amphetamine (15.8%). Buprenorphine was responsible for almost all (96.7%) of the Schedule III arrests. The benzodiazepines alprazolam (34.3%), clonazepam (33.8%), diazepam (11.9%), and lorazepam (8.5%) were listed in the preponderance of the Schedule IV arrests. Arrests increased in 2016 by 49.2% for heroin (p<0.01) and 170.0% for methamphetamine (p≤0.0005) relative to 2015. Arrests for trafficking increased by 42.9% (p<0.05). Males outnumbered females 2:1 in DA. Schedule IV agents accounted for only 6.8% of arrests for males versus 11.5% for females (p≤0.0001). Conversely, Schedule I agents were implicated in 33.0% of arrests for males versus only 27.3% for females (p<0.005).DA is an important tool for providing timely information for health care providers regarding individuals with a history of past misuse of psychotherapeutic agents, particularly opioids and stimulants." @default.
• W2620007152 created "2017-06-05" @default.
• W2620007152 creator A5005521673 @default.
• W2620007152 creator A5019645204 @default.
• W2620007152 creator A5031884954 @default.
• W2620007152 creator A5054565877 @default.
• W2620007152 creator A5068788366 @default.
• W2620007152 date "2017-06-30" @default.
• W2620007152 modified "2023-10-06" @default.
• W2620007152 title "A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program" @default.
• W2620007152 cites W1798755738 @default.
• W2620007152 cites W1842862944 @default.
• W2620007152 cites W1978507976 @default.
• W2620007152 cites W2025653942 @default.
• W2620007152 cites W2026289833 @default.
• W2620007152 cites W2028411367 @default.
• W2620007152 cites W2035786417 @default.
• W2620007152 cites W2080421146 @default.
• W2620007152 cites W2094723561 @default.
• W2620007152 cites W2108914738 @default.
• W2620007152 cites W2273108584 @default.
• W2620007152 cites W2281412879 @default.
• W2620007152 cites W2339853915 @default.
• W2620007152 cites W2344745662 @default.
• W2620007152 cites W2474827848 @default.
• W2620007152 cites W2494835558 @default.
• W2620007152 cites W2552258446 @default.
• W2620007152 cites W73578744 @default.
• W2620007152 cites W817570268 @default.
• W2620007152 doi "https://doi.org/10.1002/phar.1952" @default.
• W2620007152 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5693423" @default.
• W2620007152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28543168" @default.
• W2620007152 hasPublicationYear "2017" @default.
• W2620007152 type Work @default.
• W2620007152 sameAs 2620007152 @default.
• W2620007152 citedByCount "16" @default.
• W2620007152 countsByYear W26200071522017 @default.
• W2620007152 countsByYear W26200071522018 @default.
• W2620007152 countsByYear W26200071522019 @default.
• W2620007152 countsByYear W26200071522020 @default.
• W2620007152 countsByYear W26200071522021 @default.
• W2620007152 countsByYear W26200071522022 @default.
• W2620007152 countsByYear W26200071522023 @default.
• W2620007152 crossrefType "journal-article" @default.
• W2620007152 hasAuthorship W2620007152A5005521673 @default.
• W2620007152 hasAuthorship W2620007152A5019645204 @default.
• W2620007152 hasAuthorship W2620007152A5031884954 @default.
• W2620007152 hasAuthorship W2620007152A5054565877 @default.
• W2620007152 hasAuthorship W2620007152A5068788366 @default.
• W2620007152 hasBestOaLocation W26200071522 @default.
• W2620007152 hasConcept C118552586 @default.
• W2620007152 hasConcept C126322002 @default.
• W2620007152 hasConcept C170493617 @default.
• W2620007152 hasConcept C17744445 @default.
• W2620007152 hasConcept C199539241 @default.
• W2620007152 hasConcept C2426938 @default.
• W2620007152 hasConcept C2776029756 @default.
• W2620007152 hasConcept C2777972796 @default.
• W2620007152 hasConcept C2778858636 @default.
• W2620007152 hasConcept C2778903686 @default.
• W2620007152 hasConcept C2780035454 @default.
• W2620007152 hasConcept C2780262971 @default.
• W2620007152 hasConcept C2781063702 @default.
• W2620007152 hasConcept C2908647359 @default.
• W2620007152 hasConcept C3017944768 @default.
• W2620007152 hasConcept C512399662 @default.
• W2620007152 hasConcept C545542383 @default.
• W2620007152 hasConcept C71924100 @default.
• W2620007152 hasConcept C98274493 @default.
• W2620007152 hasConcept C99454951 @default.
• W2620007152 hasConceptScore W2620007152C118552586 @default.
• W2620007152 hasConceptScore W2620007152C126322002 @default.
• W2620007152 hasConceptScore W2620007152C170493617 @default.
• W2620007152 hasConceptScore W2620007152C17744445 @default.
• W2620007152 hasConceptScore W2620007152C199539241 @default.
• W2620007152 hasConceptScore W2620007152C2426938 @default.
• W2620007152 hasConceptScore W2620007152C2776029756 @default.
• W2620007152 hasConceptScore W2620007152C2777972796 @default.
• W2620007152 hasConceptScore W2620007152C2778858636 @default.
• W2620007152 hasConceptScore W2620007152C2778903686 @default.
• W2620007152 hasConceptScore W2620007152C2780035454 @default.
• W2620007152 hasConceptScore W2620007152C2780262971 @default.
• W2620007152 hasConceptScore W2620007152C2781063702 @default.
• W2620007152 hasConceptScore W2620007152C2908647359 @default.
• W2620007152 hasConceptScore W2620007152C3017944768 @default.
• W2620007152 hasConceptScore W2620007152C512399662 @default.
• W2620007152 hasConceptScore W2620007152C545542383 @default.
• W2620007152 hasConceptScore W2620007152C71924100 @default.
• W2620007152 hasConceptScore W2620007152C98274493 @default.
• W2620007152 hasConceptScore W2620007152C99454951 @default.
• W2620007152 hasIssue "7" @default.
• W2620007152 hasLocation W26200071521 @default.
• W2620007152 hasLocation W26200071522 @default.
• W2620007152 hasLocation W26200071523 @default.
• W2620007152 hasLocation W26200071524 @default.
• W2620007152 hasOpenAccess W2620007152 @default.
• W2620007152 hasPrimaryLocation W26200071521 @default.
• W2620007152 hasRelatedWork W1923146821 @default.

• next